Log In
Print
BCIQ
Print
Print this Print this
 

ALD-401

  Manage Alerts
Collapse Summary General Information
Company Nuo Therapeutics Inc.
DescriptionStem cells derived from bone marrow expressing high levels of aldehyde dehydrogenase
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase II
Standard IndicationStroke
Indication DetailsTreat ischemic stroke
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$44.4M

0

$28.4M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today